These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9196264)

  • 1. L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM.
    Hutson PH; Barton CL
    Eur J Pharmacol; 1997 May; 326(2-3):127-32. PubMed ID: 9196264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist.
    Morrow BA; Clark WA; Roth RH
    Eur J Pharmacol; 1993 Jul; 238(2-3):255-62. PubMed ID: 8405096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of FG 7142-induced increased dopamine utilization by the glycine/NMDA receptor antagonist (+)-HA 966.
    Horger BA; Elsworth JD; Roth RH
    J Neurochem; 1996 May; 66(5):1959-62. PubMed ID: 8780023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat.
    Claustre Y; Rivy JP; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1986 Aug; 238(2):693-700. PubMed ID: 2874216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist.
    Hutson PH; Patel S; Jay MT; Barton CL
    Eur J Pharmacol; 2004 Jan; 484(1):57-64. PubMed ID: 14729382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine: evidence for NMDA-, beta-carboline- and dopaminergic-mediated seizures in mice.
    Ushijima I; Kobayashi T; Suetsugi M; Watanabe K; Yamada M; Yamaguchi K
    Brain Res; 1998 Jun; 797(2):347-50. PubMed ID: 9666168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential decrease in dopamine utilization in prefrontal cortex by zopiclone, diazepam and zolpidem in unstressed rats.
    Boireau A; Dubedat P; Laduron PM; Doble A; Blanchard JC
    J Pharm Pharmacol; 1990 Aug; 42(8):562-5. PubMed ID: 1981584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersusceptibility to DMCM-induced seizures during diazepam withdrawal in mice: evidence for upregulation of NMDA receptors.
    Tsuda M; Shimizu N; Yajima Y; Suzuki T; Misawa M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):309-15. PubMed ID: 9550303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.
    Laird JM; Mason GS; Webb J; Hill RG; Hargreaves RJ
    Br J Pharmacol; 1996 Apr; 117(7):1487-92. PubMed ID: 8730744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area.
    Cornish JL; Nakamura M; Kalivas PW
    J Pharmacol Exp Ther; 2001 Jul; 298(1):226-33. PubMed ID: 11408546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
    Goldstein LE; Rasmusson AM; Bunney BS; Roth RH
    J Neurosci; 1994 Aug; 14(8):4937-50. PubMed ID: 8046462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B
    Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens.
    Serrano A; D'Angio M; Scatton B
    Eur J Pharmacol; 1989 Mar; 162(1):157-66. PubMed ID: 2566493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats.
    Wiley JL; Balster RL
    Life Sci; 2004 May; 75(2):141-51. PubMed ID: 15120567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization.
    Tam SY; Roth RH
    J Pharmacol Exp Ther; 1990 Mar; 252(3):989-96. PubMed ID: 2157001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324.
    Kotlinska J; Liljequist S
    Psychopharmacology (Berl); 1998 Jan; 135(2):175-81. PubMed ID: 9497023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine prevention of swim stress-induced sensitization of cortical biogenic amines: an in vivo microdialysis study.
    Petty F; Jordan S; Kramer GL; Zukas PK; Wu J
    Neurochem Res; 1997 Sep; 22(9):1101-4. PubMed ID: 9251099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.